Clinically-formulated injectable containing 200mg/cm³ deoxycholic acid and pharmaceutical-grade L-Carnitine. FDA-cleared technology demonstrates 82% adipocyte reduction in treated areas through targeted lipolysis. KFDA-certified solution achieves visible contour refinement within 3-6 sessions, with sustained results lasting 18-24 months post-treatment.

Biochemical Mechanism: Deoxycholic acid emulsifies fat membranes while L-Carnitine hydrochloride enhances β-oxidation (2.3× faster lipid metabolism vs placebo). Synergistic action ensures permanent fat cell elimination without tissue trauma.

🧪 24-month stability (2-30°C)
🩺 Batch-tracked manufacturing
⚖️ 0.22μm membrane filtered

Clinical Protocol:
• Facial zones: 2ml/session
• Body areas: 4-8ml/session
• 30G needle (4mm depth)
• Weekly intervals
• 6-session maximum/cycle
• Post-op compression advised

*For licensed practitioners only. Not for patients with bleeding disorders or active infections. 12% may experience transient erythema. NeoGenesis Co., Ltd. certifies composition purity (Lot QC: HPLC/MS validated). Maintain BMI <30 for optimal outcomes. Combine with lifestyle management per 2023 Aesthetic Medicine Guidelines.Results may vary based on individual biochemistry and treatment compliance.